Reported Tuberculosis in the United States, 2021

Return to Main Menu

Table 24. National Tuberculosis Genotyping Surveillance Coverage:1 United States, 2004–2021

See Surveillance Slide #59.

Tuberculosis genotyping surveillance coverage.
Year Total cases Culture-positive cases Genotyped cases Coverage (%)
2021 7,882 6,244 6,075 (97.3)
2020 7,171 5,697 5,586 (98.1)
2019 8,898 7,101 6,966 (98.1)
2018 8,998 7,096 6,948 (97.9)
2017 9,069 7,129 6,946 (97.4)
2016 9,240 7,171 6,988 (97.4)
2015 9,538 7,413 7,201 (97.1)
2014 9,382 7,217 6,972 (96.6)
2013 9,539 7,356 7,049 (95.8)
2012 9,923 7,616 7,224 (94.9)
2011 10,474 8,059 7,593 (94.2)
2010 11,071 8,390 7,684 (91.6)
2009 11,494 8,863 7,700 (86.9)
2008 12,943 10,083 8,176 (81.1)
2007 13,274 10,439 8,425 (80.7)
2006 13,720 10,747 7,528 (70.0)
2005 14,053 10,955 7,497 (68.4)
2004 14,498 11,330 5,954 (52.6)

1Genotype surveillance coverage is defined as the percentage of all culture positive tuberculosis (TB) cases for which there was a genotyped isolate.

Note: This table reflects genotyping surveillance coverage for the 50 states and the District of Columbia; for genotyping surveillance coverage of the U.S.-affiliated reporting areas, please see Table 25.